WallStreetZenWallStreetZen
Analyst Ranking
Top 2%
#53 out of 4420 analysts
Average Return
+39.73%
Win Rate
53%39 out of 74
Risk vs Reward
Poor
Good

Derek Archila's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cabaletta Bio IncCABA
+1,563.62%$0.87$14.54
2022-09-13 -
2023-09-13
Strong Buy
Prometheus Biosciences IncRXDX
+604.58%$27.52$193.90
2022-05-12 -
2023-05-12
Strong Buy
Prometheus Biosciences IncRXDX
+294.01%$50.74$199.92
2022-08-28 -
2023-06-15
Strong Buy
Prometheus Biosciences IncRXDX
+185.97%$33.50$95.80
2021-12-07 -
2022-12-07
Strong Buy
Ngm Biopharmaceuticals IncNGM
+167.08%$11.30$30.18
2020-03-18 -
2021-03-19
Strong Buy

Derek Archila Analyst Color

Get additional color on Derek Archila's coverage of popular stocks

Derek Archila's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Kezar Life Sciences IncKZR
8Hold$2.00+133.92%Maintains
22 days ago
Celldex Therapeutics IncCLDX
2Hold$27.00-14.75%Upgrades
a month ago
Rhythm Pharmaceuticals IncRYTM
2Strong Buy$40.00+8.67%Maintains
a month ago
Immunovant IncIMVT
8Strong Buy$48.00+20.21%Maintains
2 months ago
Cabaletta Bio IncCABA
4Strong Buy$39.00+149.52%Maintains
3 months ago
Apellis Pharmaceuticals IncAPLS
5Strong Buy$64.00-1.27%Upgrades
3 months ago
Ascendis Pharma AASND
7Strong Buy$134.00+26.87%Maintains
3 months ago
Zentalis Pharmaceuticals IncZNTL
2Strong Buy$50.00+329.18%Maintains
4 months ago
Argenx SeARGX
4Strong Buy$609.00+32.52%Maintains
4 months ago
Dice Therapeutics IncDICE
2Hold$48.00+0.95%Maintains
6 months ago
Morphosys AgMOR
1Strong Buy$17.00+124.27%Initiates Coverage On
6 months ago
Blueprint Medicines CorpBPMC
5Hold$55.00-24.98%Maintains
6 months ago
Morphic Holding IncMORF
5Strong Buy$80.00+219.23%Maintains
7 months ago
Zymeworks IncZYME
1Strong Buy$12.00+33.19%Assumes
9 months ago
Ventyx Biosciences IncVTYX
1Strong Buy$77.00+3,549.29%Initiates Coverage On
9 months ago
Exelixis IncEXEL
1Strong Buy$23.00+5.17%Initiates Coverage On
9 months ago
Kymera Therapeutics IncKYMR
4Strong Buy$42.00+103.78%Maintains
a year ago
Incyte CorpINCY
3Hold$75.00+36.81%Maintains
a year ago
C4 Therapeutics IncCCCC
3Hold$9.00+508.11%Maintains
a year ago
Arvinas IncARVN
2Hold$49.00+111.48%Downgrades
a year ago
Monte Rosa Therapeutics IncGLUE
2Strong Buy$19.00+522.95%Upgrades
a year ago
Horizon Therapeutics Public Ltd CoHZNP
2Hold$116.50+0.17%Downgrades
a year ago
Prometheus Biosciences IncRXDX
4Strong Buy$71.00N/AMaintains
a year ago
Nurix Therapeutics IncNRIX
3Strong Buy$25.00N/AUpgrades
2 years ago
Arena Pharmaceuticals IncARNA
1Strong Buy$71.00N/AInitiates Coverage On
2 years ago
Esperion Therapeutics IncESPR
1Hold$20.00N/ADowngrades
3 years ago
Lumos Pharma IncLUMO
1Strong Buy$24.00N/AUpgrades
3 years ago
Momenta Pharmaceuticals IncMNTA
2Hold$52.50N/ADowngrades
3 years ago
Principia Biopharma IncPRNB
1Hold$100.00N/ADowngrades
3 years ago
Inventiva SaIVA
1Strong Buy$18.00N/AInitiates Coverage On
3 years ago
Genfit SaGNFT
1Strong BuyN/AN/AUpgrades
3 years ago
Galapagos NvGLPG
1Hold$193.00N/ADowngrades
3 years ago
Viela Bio IncVIE
1Hold$58.00N/AInitiates Coverage On
3 years ago
Cymabay Therapeutics IncCBAY
1Strong Buy$8.00N/AUpgrades
4 years ago
Oneok IncOKE
1Strong Buy$41.00N/AReiterates
4 years ago
Amarin Corp PLCAMRN
2Hold$8.00N/AMaintains
4 years ago
Ngm Biopharmaceuticals IncNGM
1Strong Buy$32.00N/AMaintains
4 years ago
Dbv Technologies SaDBVT
2Hold$6.00N/ADowngrades
4 years ago
Vanda Pharmaceuticals IncVNDA
4Hold$29.00N/ADowngrades
5 years ago
Heron Therapeutics IncHRTX
2Buy$50.00N/AMaintains
5 years ago
Urogen Pharma LtdURGN
1Buy$51.00N/AMaintains
6 years ago
Perrigo Co PLCPRGO
1Buy$88.00N/AInitiates Coverage On
6 years ago
Pacira Biosciences IncPCRX
1HoldN/AN/AInitiates Coverage On
6 years ago
Zynerba Pharmaceuticals IncZYNE
1HoldN/AN/ADowngrades
6 years ago
Teva Pharmaceutical Industries LtdTEVA
1HoldN/AN/ADowngrades
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.